Douglas Carr Sells $131 of Century Therapeutics Inc (IPSC) — SEC Form 4, Sep 10, 2025
Open-Market Net Sale · SEC Form 4
−$131
Equity position changed by -0.1%
Equity Position
405K sh
405,686 → 405,423
Equity Change
-0.1%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Douglas Carr CIK 0001867173 |
SVP
|
Douglas Carr at Century Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$28,577
More from this insider at Century Therapeutics Inc
| 2026-09-15 | Sell | -$3,200 | View |
| 2026-09-09 | Sell | -$521 | View |
| 2026-08-05 | Sell | -$544 | View |
| 2026-06-15 | Sell | -$3,692 | View |
| 2026-06-09 | Sell | -$526 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2025-09-08 | S - Sale | 263 D | $0.50 | -$132 | 405,423 | Direct |
Footnotes (1)
- F1
- The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Show more
Related filings at Century Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
100
institutional managers reporting a position
Largest by reported value
- Ra Capital Management, L.P. $43.5M
- Tcg Crossover Management, Llc $43.4M
- Versant Venture Management, Llc $29.8M
5%+ Holders · 13D/G
6 filers
Other insiders at Century Therapeutics Inc
GET /v1/forms/4/0001062993-25-015526
API docs
View Original SEC Filing